Skip to main content
Clinical Trials/NL-OMON30174
NL-OMON30174
Not yet recruiting
Not Applicable

Positron Emission Tomography as a diagnostic tool in Unilateral Condylar Hyperplasia and comparison with bone scintigraphy, including SPECT - PET and Unilateral Condylar Hyperplasia

Vrije Universiteit Medisch Centrum0 sites6 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Temporo-Mandibulaire Gewricht
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
6
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • suspicion of progressive mandibulair asymmetry and clinical suspicion of an unilateral condylar hyperplasia.
  • Age 18\-40 years

Exclusion Criteria

  • The inability of lying on the back during 1 hour
  • Nuclear or radiologic research in the year prior to this study, with a yeardose of more than 10 mSv

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Clinical study using positron emission tomography(PET)brain tumor,epilepsy,multiple sclerosis, neuromyelitis,Duchenne musclar dystrophy,Alzheimer&#39s disease,Down Syndrome,Hydrocephalus
JPRN-UMIN000005626Center for Integrated Human Brain Science, Brain Research Institute, University of Niigata100
Completed
Not Applicable
Clinical relevance of Positron Emission Tomography (PET) imaging following endovascular aneurysm repair using the Nellix endoprosthesis.Abdominal aortic aneurysmenlarged artery of the abdominal aorta10002363
NL-OMON40667Rijnstate Ziekenhuis10
Recruiting
Not Applicable
Positron Emission Tomography for detection of histologic transformation of indolent non-Hodgkin*s lymphoma: a pilot studyfollicular lymphomalow grade lymphoma10025320
NL-OMON32557Vrije Universiteit Medisch Centrum34
Not yet recruiting
Not Applicable
Positron Emission Tomography with AT-01 to Diagnose and Monitor Amyloidosis: A Prospective Cohort Pilot Study.AmyloidosisBlood - Haematological diseasesCardiovascular - Other cardiovascular diseasesMetabolic and Endocrine - Other metabolic disordersNeurological - Other neurological disordersOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
ACTRN12624000755538Metro South Health30
Completed
Phase 1
A PET (positron emission tomography) clinical research study using prostate specific membrane antigen (PSMA) targeted tracer, 89Zr-Df-IAB2MProstate cancer / Urothelial carcinoma / Renal cell carcinoma / Testicular cancer
JPRN-UMIN000015356niversity of Tsukuba15